Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer. - Wikidata - awgldk - TriplyDB

Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.

Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.

http://www.wikidata.org/entity/Q37390674

about

Multimodality Image Fusion with PSMA PET/CT and High-Intensity Focused Ultrasound Focal Therapy for Primary Diagnosis and Management of Prostate Cancer: A Planned Research Initiative.Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study.Radiotheranostics in Cancer Diagnosis and Management.Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma.Advances in prostate-specific membrane antigen PET of prostate cancer.Molecular imaging of prostate cancer.Magnetic Gold Nanoparticle-Labeled Heparanase Monoclonal Antibody and its Subsequent Application for Tumor Magnetic Resonance Imaging.

P2860

Q38641232-6F6EF378-2A9A-4DD1-AA26-C28BDC4F9D71 Q38665724-37D9978C-6DCD-4FA3-A9E7-147DE6AB5756 Q47719762-27BA5F5C-8A39-48F4-A1D6-863080A0439B Q47724407-8AEA0EC4-C852-4790-85B3-131C0E6B1AD0 Q49713199-6A3A5892-94EF-440A-8B08-AB845D90F2E1 Q52411549-BDE22B48-FC74-4AA8-AC97-5DD8A54BBF82 Q55001830-7AF4792F-AFD4-467B-8387-1253E32BD4FF

P2860

Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.

http://www.wikidata.org/entity/Q37390674

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prostate-Specific Membrane Ant ...... ic Agents for Prostate Cancer.

@en

Prostate-Specific Membrane Ant ...... ic Agents for Prostate Cancer.

@nl

type

label

Prostate-Specific Membrane Ant ...... ic Agents for Prostate Cancer.

@en

Prostate-Specific Membrane Ant ...... ic Agents for Prostate Cancer.

@nl

prefLabel

Prostate-Specific Membrane Ant ...... ic Agents for Prostate Cancer.

@en

Prostate-Specific Membrane Ant ...... ic Agents for Prostate Cancer.

@nl

P1433

Q37390674-6372176E-FD8F-459F-A2A8-EB8AA202B2A6

P1476

Q37390674-40D00F19-0884-4122-80E4-F02E84A3F7FE

P2093

Q37390674-1BF8587D-7AE3-4C2F-A37B-67EE0E081750

Q37390674-26F5CC3F-EEC7-41D6-AB9B-AAD9F421274A

Q37390674-634F3AD1-E619-4E9B-AB71-8B575B1B6E91

Q37390674-AECAF419-10CE-4627-936E-35E8A3B9F451

Q37390674-BFC0978F-CDC8-4D15-9BE6-68E82378B4BC

P2860

Q37390674-02EC9C76-CC7A-41A0-8C05-B66369FD4467

Q37390674-05F6A83C-46DC-4323-BED8-47F120823082

Q37390674-08B82885-4E29-46C5-AF1E-48891C35F89E

Q37390674-0AE9AB4C-E390-4154-B7F5-CD826F95C189

Q37390674-0C93EE74-7877-48A1-978F-FA617B4745D3

Q37390674-13309240-D640-480D-876B-782F2E787C78

Q37390674-14701CB8-A775-4398-B223-4A84580AF109

Q37390674-16A5CD54-98AB-4DB9-A02A-051B5AF73B6A

Q37390674-1B3CF456-363A-4F1F-8AB6-3A4E5BF75A41

Q37390674-27DF5F8F-9DA0-4B93-B2C4-94CB7BD5E002

P304

Q37390674-02E94011-D642-464A-A373-CC5D3A7AAB50

P31

Q37390674-8F7E07DE-579D-4120-A4D9-2BE91641AB56

P356

Q37390674-D6031B47-DF1D-4B59-B859-53CE0ECB798C

P407

Q37390674-B10F5E38-1961-4032-B812-EEBAA3282A38

P433

Q37390674-817B7AC1-8234-4A08-8082-D3BBECC9EAF0

P478

Q37390674-595BC488-83D1-46CC-A950-D372B7107D9E

P50

Q37390674-9203F946-57C0-4AFC-81EA-859A5AF32C1B

Q37390674-E5D93370-8FA8-4980-8E60-62E07C9EF50B

P577

Q37390674-22FBC846-0375-4359-9D63-46D038265165

P698

Q37390674-5494942D-3702-49F1-A55C-2B0297C41397

P932

Q37390674-F76C6F13-9317-4F7F-818A-B34F6297FB8E

P356

JNUMED.115.170175

P1433

The Journal of Nuclear Medicine

P1476

Prostate-Specific Membrane Ant ...... ic Agents for Prostate Cancer.

@en

P2093

Bernd Neumaier

http://www.w3.org/2001/XMLSchema#string

Markus Dietlein

http://www.w3.org/2001/XMLSchema#string

Martin G Pomper

http://www.w3.org/2001/XMLSchema#string

Michael R Zalutsky

http://www.w3.org/2001/XMLSchema#string

Steven P Rowe

http://www.w3.org/2001/XMLSchema#string

P2860

Prostate-specific membrane antigen as a target for cancer imaging and therapy

Global cancer statistics, 2012

Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer

Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer

Indium-111 capromab pendetide in the management of recurrent prostate cancer

NAAG peptidase inhibitors and their potential for diagnosis and therapy

Prostate-specific membrane antigen expression as a predictor of prostate cancer progression

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.

Impact of biochemical recurrence in prostate cancer among US veterans.

P304

90S-96S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.115.170175

http://www.w3.org/2001/XMLSchema#string

P407

P433

Suppl 3

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Drzezga

Michael A Gorin

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27694179

http://www.w3.org/2001/XMLSchema#string

P932

5093916

http://www.w3.org/2001/XMLSchema#string